Christopher S. Hackett

3.5k citations
25 papers · 2.4k · 1 hit paper · h-index 19

Impact in

  • Oncology top 2%
    • CAR-T cell therapy research
  • Genetics top 5%
    • Virus-based gene therapy research
    • Glioma Diagnosis and Treatment

Papers in

Christopher S. Hackett

25 papers receiving 2.4k citations

Christopher S. Hackett's Hit Papers

Engineering strategies to overcome the current roadblocks in CAR T cell therapy 2019 · 1.1k citations
1.1k0+2+4Years since publication2505007501000

Peers

Christopher S. Hackett
Comparison fields: 5 of 103
  • Oncology 1.1k
  • Genetics 255
  • Immunology 492
  • Molecular Biology 1.1k
  • Cancer Research 215
Replace Liqing Jin with:
Liqing Jin Canada
Edward R. Kastenhuber United States
Tarik Regad United Kingdom
Marta M. Alonso Spain
Mindaugas Valius Lithuania
Jian Qiao United States
Claudia Kowolik United States
Christopher G. Hubert United States
Leo Kretzner United States
Dieter Zopf Germany
Christopher S. Hackett relative to Liqing Jin Canada Liqing Jin's profile →
Citations per field
00.5×1.5×2.5×
Liqing Jin · 1×
Citations per year

Countries citing papers authored by Christopher S. Hackett

Since Specialization
Citations

This map shows the geographic impact of Christopher S. Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher S. Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher S. Hackett more than expected).

Fields of papers citing papers by Christopher S. Hackett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher S. Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher S. Hackett. The network helps show where Christopher S. Hackett may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher S. Hackett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher S. Hackett Line = papers co-authored together Christopher S. Hackett links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Hit paper breakdown →
20191100
2 2007171
3 2012163
4
Genetic determinants of malignancy in a mouse model for oligodendroglioma.
2003145
5 199595
6
Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.
200390
7 199673
8 201269
9 201268
10 200664
11 200959
12 198453
13 200748
14 198840
15 199039
16 200731
17 198631
18 198819
19 198118
20 201316

About Christopher S. Hackett

Christopher S. Hackett is a scholar working on Molecular Biology, Neurology, Oncology, Pediatrics, Perinatology and Child Health and Genetics, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (5 papers), CAR-T cell therapy research (5 papers), Neonatal Health and Biochemistry (4 papers), CRISPR and Genetic Engineering (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Amino Acid Enzymes and Metabolism (2 papers), Influenza Virus Research Studies (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (1.1k citations), Genetics (255 citations), Immunology (492 citations), Molecular Biology (1.1k citations) and Cancer Research (215 citations). Christopher S. Hackett has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Sarwish Rafiq, Renier J. Brentjens, William A. Weiss, Philipp Strittmatter, Juris Ozols, Theodore Nicolaides, Perry B. Hackett, Christine Cheng, Aron M. Geurts and Zachary A. Knight. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, The Journal of Infectious Diseases, Molecular Therapy and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact